文献速递肾小球疾病慢性肾脏病

法布雷肾病足细胞球三糖神经酰胺蓄积与足细胞进行性丢失相关

Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss.
PubMed 文献 · J Am Soc Nephrol · 2020-03-03

本研究对55例经典法布雷病男性患者(平均27岁)及7例活体移植供肾对照进行非偏倚定量形态计量电镜研究,发现足细胞GL3体积分数随年龄增长至约27岁,并与足细胞损伤和丢失相关;足细胞结构参数恶化同时与尿蛋白排泄增加和GFR下降相关,提示足细胞损伤和丢失在法布雷肾病进展中起重要作用。

要点

  • 足细胞GL3体积分数随年龄增长至约27岁,超过阈值可能影响足细胞存活。
  • GL3蓄积与足突宽度增加和足细胞数量密度下降相关,提示足细胞损伤和丢失。
  • 足细胞结构参数恶化与尿蛋白排泄增加和GFR下降相关,需在关键足细胞丢失前干预。

核心结论

  • 法布雷肾病中足细胞GL3蓄积与足细胞损伤和丢失相关,提示足细胞损伤和丢失在疾病进展中起重要作用。

研究设计与样本

  • 研究纳入55例经典法布雷病基因型和/或表型男性患者(平均年龄27岁)及7例活体移植供肾对照,进行非偏倚定量形态计量电镜研究。

主要发现

  • 足细胞GL3体积分数随年龄增长至约27岁,提示超过阈值可能影响足细胞存活。
  • GL3蓄积与足突宽度增加和足细胞数量密度下降相关。
  • 足细胞GL3体积分数和足突宽度增加与尿蛋白排泄增加及GFR下降相关。

临床怎么用

  • 提示需在关键足细胞丢失发生前进行治疗干预,以延缓法布雷肾病进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In males with classic Fabry disease, the processes leading to the frequent outcome of ESKD are poorly understood. Defects in the gene encoding α-galactosidase A lead to accumulation of globotriaosylceramide (GL3) in various cell types. In the glomerular podocytes, accumulation of GL3 progresses with age. Of concern, podocytes are relatively resistant to enzyme replacement therapy and are poorly replicating, with little ability to compensate for cell loss. METHODS: In this study of 55 males (mean age 27 years) with classic Fabry disease genotype and/or phenotype, we performed unbiased quantitative morphometric electron microscopic studies of biopsied kidney samples from patients and seven living transplant donors (to serve as controls). We extracted clinical information from medical records and clinical trial databases. RESULTS: Podocyte GL3 volume fraction (proportion of podocyte cytoplasm occupied by GL3) increased with age up to about age 27, suggesting that increasing podocyte GL3 volume fraction beyond a threshold may compromise survival of these cells. GL3 accumulation was associated with podocyte injury and loss, as evidenced by increased foot process width (a generally accepted structural marker of podocyte stress and injury) and with decreased podocyte number density per glomerular volume. Worsening podocyte structural parameters (increasing podocyte GL3 volume fraction and foot process width) was also associated with increasing urinary protein excretion-a strong prognosticator of adverse renal outcomes in Fabry disease-as well as with decreasing GFR. CONCLUSIONS: Given the known association between podocyte loss and irreversible FSGS and global glomerulosclerosis, this study points to an important role for podocyte injury and loss in the progression of Fabry nephropathy and indicates a need for therapeutic intervention before critical podocyte loss occurs.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Najafian B, Tøndel C, Svarstad E, et al. Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss. J Am Soc Nephrol. 2020. PMID: 32127409. doi:10.1681/ASN.2019050497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。